US Patent:
20110224226, Sep 15, 2011
Inventors:
Robert E. DESJARDINS - Allendale NJ, US
Rudolph Lucek - Bernardsville NJ, US
International Classification:
A61K 31/496
A61P 7/00
Abstract:
Disclosed in certain embodiments is an oral pharmaceutical dosage form of a pharmaceutically acceptable excipient and an effective amount of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl} pyridin-2-yl)piperadine-4-carboxylic acid (Formula I) or a pharmaceutically acceptable salt thereof, to increase platelet levels in humans.